SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
Evolving from a cleaning-tech champion into a full-home lifestyle brand, DREAME begins with core categories like refrigeration and laundry, using flagship innovation and a...
HONG KONG, Dec. 18, 2025 /PRNewswire/ -- For Hong Kong enterprises acting as the bridge between Mainland China and the global market, email reliability...
SEOUL, South Korea, Dec. 18, 2025 /PRNewswire/ -- CorestemChemon (KOSDAQ: 166480) is entering a critical late-stage phase in the commercialization of its ALS stem...
SUZHOU, China, Dec. 18, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN027, an independently...
HANGZHOU, China, Dec. 18, 2025 /PRNewswire/ -- On December 12, the second Silk Fashion Gala opened at the China National Silk Museum in Hangzhou, bringing...